Elucid builds FDA-cleared AI software that analyzes cardiac CT scans to characterize plaque and predict heart attack and stroke risk. The world's best cardiologists use our output to make treatment decisions for real patients. As such, our platform is regulated as a Software as a Medical Device (SaMD) product by the FDA and we operate under HIPAA, ISO 13485, and ISO 27001.